HER2-targeting antibody–drug conjugate RC48 alone or in combination with immunotherapy for locally advanced or metastatic urothelial carcinoma: a multicenter, real-world study

被引：0
|
作者：
Meiting Chen
Kai Yao
Manming Cao
Hao Liu
Cong Xue
Tao Qin
Lingru Meng
Zhousan Zheng
Zike Qin
Fangjian Zhou
Zhuowei Liu
Yanxia Shi
Xin An
机构：
[1] Sun Yat-Sen University Cancer Center,Department of Medical Oncology
[2] State Key Laboratory of Oncology in South China,Department of Urology
[3] Collaborative Innovation Center for Cancer Medicine,Department of Medical Oncology, Zhujiang Hospital
[4] Sun Yat-Sen University Cancer Center,Department of Urology, Sun Yat
[5] State Key Laboratory of Oncology in South China,Sen Memorial Hospital
[6] Collaborative Innovation Center for Cancer Medicine,Department of Medical Oncology, Sun Yat
[7] Southern Medical University,Sen Memorial Hospital
[8] Sun Yat-Sen University,Ward 2, Department of Oncology
[9] Yuexiu District,Department of Medical Oncology, the First Affiliated Hospital
[10] Sun Yat-Sen University,undefined
[11] Hainan Cancer Hospital,undefined
[12] Sun Yat-Sen University,undefined
来源：
Cancer Immunology, Immunotherapy | 2023年 / 72卷
关键词：
Metastatic urothelial carcinoma; Anti-HER2 antibody–drug conjugate; RC48; Real-world study;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2309 / 2318
页数：9
相关论文
共 8 条
  • [1] HER2-targeting antibody-drug conjugate RC48 alone or in combination with immunotherapy for locally advanced or metastatic urothelial carcinoma: a multicenter, real-world study
    Chen, Meiting
    Yao, Kai
    Cao, Manming
    Liu, Hao
    Xue, Cong
    Qin, Tao
    Meng, Lingru
    Zheng, Zhousan
    Qin, Zike
    Zhou, Fangjian
    Liu, Zhuowei
    Shi, Yanxia
    An, Xin
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2023, 72 (07) : 2309 - 2318
  • [2] The effectiveness and safety of RC48 alone or in combination with PD-1 inhibitors for locally advanced or metastatic urothelial carcinoma: a multicenter, real-world study
    Ge, Huaixi
    Liu, Changxue
    Shen, Chengquan
    Hu, Ding
    Zhao, Xinzhao
    Wang, Yanhua
    Ge, Huimin
    Qin, Ruize
    Ma, Xiaocheng
    Wang, Yonghua
    JOURNAL OF TRANSLATIONAL MEDICINE, 2025, 23 (01)
  • [3] RC48-Antibody-Drug Conjugate in Metastatic Urothelial Carcinoma: A Multicenter Real-World Study in China
    Chen, Jinchao
    Wang, Mingchao
    Qi, Xiaolong
    Long, Huimin
    Qi, Nienie
    Wu, Lingfeng
    Ke, Mang
    Shao, Sihai
    Li, Peng
    Chen, Yongliang
    Wang, Wei
    Zhu, Shaoxing
    Qi, Xiaoping
    Li, Gonghui
    CLINICAL GENITOURINARY CANCER, 2024, 22 (03)
  • [4] RC48-ADC monotherapy or in combination with immunotherapy for locally advanced or metastatic urothelial carcinoma with HER2 low and null expression: a multicenter, real-world, retrospective study
    Daining Wang
    Manming Cao
    Yijun Zhang
    Liangkuan Bi
    Meiting Chen
    Mengqian Ni
    Qiufan Zheng
    Kai Yao
    Zhuowei Liu
    Xia Yang
    Yanxia Shi
    Zhiming Wu
    Xin An
    BMC Cancer, 25 (1)
  • [5] Real-world effectiveness and safety of RC48-ADC alone or in combination with PD-1 inhibitors for patients with locally advanced or metastatic urothelial carcinoma: A multicenter, retrospective clinical study
    Xu, Jingwei
    Zhang, Hongqiao
    Zhang, Li
    Chu, Xiufeng
    Li, Yu
    Li, Guangyuan
    Nie, Caiyun
    Wang, Meng
    Guo, Yanwei
    CANCER MEDICINE, 2023, 12 (23): : 21159 - 21171
  • [6] Efficacy and safety of RC48 in combination with PD-1 inhibitors for the treatment of locally advanced or metastatic urothelial carcinoma: a single-center, real-world study
    Tiantian Zhang
    Shuo He
    Lu Tao
    Mengting Shi
    Yue Wu
    Yuanyuan Guo
    Rui Wang
    Discover Oncology, 16 (1)
  • [7] Avelumab First-Line Maintenance for Locally Advanced or Metastatic Urothelial Carcinoma: Results From the Real-World US PATRIOT-II Study
    Grivas, Petros
    Barata, Pedro
    Moon, Helen
    Gupta, Shilpa
    Hutson, Thomas
    Sternberg, Cora N.
    Brown, Jason R.
    Dave, Vaidehi
    Downey, Chad
    Shillington, Alicia C.
    Katzenstein, Howard M.
    Kirker, Melissa
    Hanson, Sarah
    Liu, Frank X.
    Morris, Valerie
    Bhanegaonkar, Abhijeet
    Sonpavde, Guru P.
    CLINICAL GENITOURINARY CANCER, 2024, 22 (06)
  • [8] Treatment Patterns, Healthcare Resource Utilization, and Costs Among Patients Diagnosed With Locally Advanced/Metastatic Urothelial Carcinoma Prior to Receiving Enfortumab Vedotin: A Real-World Evidence Study
    Morgans, Alicia K.
    Mucha, Lisa
    Quicquaro, Christina
    Shih, Vanessa
    Xie, Bin
    Young, Christopher
    Yang, Hongbo
    Liu, Qing
    Greatsinger, Alexandra
    Lax, Angela
    INTERNATIONAL JOURNAL OF UROLOGY, 2025,
1